105 related articles for article (PubMed ID: 9267101)
21. [Taxanes: a breakthrough in cancer chemotherapy].
Inbar M; Merimsky O; Chaitchik S
Harefuah; 1997 Jul; 133(1-2):31-6. PubMed ID: 9332055
[No Abstract] [Full Text] [Related]
22. Docetaxel: assessing a range of activity.
Aapro M; Rowinsky E
Anticancer Drugs; 2001 Feb; 12 Suppl 1():S1-3. PubMed ID: 11340897
[No Abstract] [Full Text] [Related]
23. The development of docetaxel (Taxotere) in non-small cell lung cancer.
Kris MG; Miller VA; Ng KK; Grant SC
Semin Oncol; 1997 Aug; 24(4 Suppl 14):S14-1-S14-4. PubMed ID: 9335515
[No Abstract] [Full Text] [Related]
24. [Progress and perspectives in palliative therapy of breast carcinoma].
Verlag GT
Dtsch Med Wochenschr; 1996 Dec; 121(49 Suppl):1-8. PubMed ID: 8983911
[No Abstract] [Full Text] [Related]
25. Docetaxel (Taxotere) in the treatment of non-small cell lung cancer: recent results and future developments.
Rosell R
Semin Oncol; 1999 Jun; 26(3 Suppl 11):1-3. PubMed ID: 10458202
[No Abstract] [Full Text] [Related]
26. Paclitaxel and docetaxel in breast and ovarian cancer.
Drug Ther Bull; 1997 Jun; 35(6):43-6. PubMed ID: 9282422
[TBL] [Abstract][Full Text] [Related]
27. Docetaxel (Taxotere) in the treatment of cancer.
Burris HA
Semin Oncol; 2000 Apr; 27(2 Suppl 3):1-2. PubMed ID: 10810931
[No Abstract] [Full Text] [Related]
28. Docetaxel (taxotere, Rhone-Poulenc Rorer).
MacConnachie AM
Intensive Crit Care Nurs; 1997 Apr; 13(2):119-20. PubMed ID: 9180501
[TBL] [Abstract][Full Text] [Related]
29. The scientific rationale for developing taxoids.
Aapro M
Anticancer Drugs; 1996 Aug; 7 Suppl 2():33-6. PubMed ID: 8862709
[TBL] [Abstract][Full Text] [Related]
30. [Adjuvant chemotherapy for breast cancer and targeted therapies].
Dufresne A; Bachelot T; Blay JY
Rev Prat; 2008 Mar; 58(5):477-8. PubMed ID: 18524101
[No Abstract] [Full Text] [Related]
31. Taxoids in head and neck cancer: the American approach.
Forastiere AA
Acta Otorhinolaryngol Belg; 1999; 53(3):253-7. PubMed ID: 10635404
[TBL] [Abstract][Full Text] [Related]
32. [Taxotere: the first drug better than acrdiamycin, the most frequently used drug in the treatment of metastasized breast cancer. Phase III study shows a better response than standard treatment].
Oncologica; 1997 Aug; 14(3):23-4. PubMed ID: 9481342
[No Abstract] [Full Text] [Related]
33. Taxotere.
Renick-Ettinger A
J Pediatr Oncol Nurs; 1996 Jan; 13(1):43-5. PubMed ID: 8904466
[No Abstract] [Full Text] [Related]
34. Taxoids, a new class of antitumour agents of plant origin: recent results.
Potier P; Guéritte-Voegelein F; Guénard D
Nouv Rev Fr Hematol (1978); 1994; 36 Suppl 1():S21-3. PubMed ID: 7909940
[TBL] [Abstract][Full Text] [Related]
35. Introduction: taxoids and the management of breast cancer.
Hortobagyi GN
Semin Oncol; 1997 Aug; 24(4 Suppl 13):S13-1-S13-2. PubMed ID: 9335510
[No Abstract] [Full Text] [Related]
36. [Taxotere in various solid tumors].
Orel NF
Vopr Onkol; 1998; 44(5):639-44. PubMed ID: 9925501
[No Abstract] [Full Text] [Related]
37. Use caution when managing paclitaxel and taxotere infiltrations.
Goodman M; Stewart I; Lydon J; Blendowski C; Barnicle M; Petersen J; Wickham R
Oncol Nurs Forum; 1996 Apr; 23(3):541-2. PubMed ID: 8801516
[No Abstract] [Full Text] [Related]
38. [The administration of Docetaxel (taxoter): a new stage in chemotherapy of cancer].
Evtushenko OI
Klin Khir; 1999; (8):48-52. PubMed ID: 10584502
[No Abstract] [Full Text] [Related]
39. Docetaxel (Taxotere): preclinical and general clinical information.
Earhart RH
Semin Oncol; 1999 Oct; 26(5 Suppl 17):8-13. PubMed ID: 10604262
[TBL] [Abstract][Full Text] [Related]
40. Taxoids in combination with anthracyclines and other agents: pharmacokinetic considerations.
D'Incalci M; Schüller J; Colombo T; Zucchetti M; Riva A
Semin Oncol; 1998 Dec; 25(6 Suppl 13):16-20. PubMed ID: 9865687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
